FY2024 EPS Estimates for Nano-X Imaging Decreased by Analyst

Nano-X Imaging Ltd. (NASDAQ:NNOX) – Analysts at Cantor Fitzgerald cut their FY2024 earnings estimates for shares of Nano-X Imaging in a note issued to investors on Tuesday, November 26th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will post earnings of ($0.96) per share for the year, down from their previous forecast of ($0.89). Cantor Fitzgerald has a “Overweight” rating and a $11.00 price target on the stock. The consensus estimate for Nano-X Imaging’s current full-year earnings is ($0.88) per share.

Nano-X Imaging Stock Performance

NASDAQ NNOX opened at $6.28 on Thursday. The stock has a market capitalization of $362.85 million, a P/E ratio of -7.39 and a beta of 2.01. Nano-X Imaging has a 52 week low of $5.26 and a 52 week high of $14.28. The stock has a fifty day moving average of $6.05 and a 200-day moving average of $7.04.

Institutional Trading of Nano-X Imaging

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC bought a new stake in shares of Nano-X Imaging during the third quarter worth approximately $25,000. Price T Rowe Associates Inc. MD raised its position in shares of Nano-X Imaging by 13.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,716 shares of the company’s stock valued at $135,000 after acquiring an additional 1,612 shares during the last quarter. Verition Fund Management LLC acquired a new position in shares of Nano-X Imaging in the 3rd quarter valued at $88,000. State Board of Administration of Florida Retirement System boosted its position in shares of Nano-X Imaging by 17.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 16,000 shares of the company’s stock worth $156,000 after purchasing an additional 2,380 shares during the last quarter. Finally, Creative Planning acquired a new stake in shares of Nano-X Imaging during the third quarter worth $107,000. 21.49% of the stock is owned by institutional investors.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.